Professor Mark Shackleton (MBBS PhD FRACP) is the Director of Oncology at Alfred Health, a Professor of Oncology in the Department of Medicine at Monash University, the Chair of Melanoma and Skin Trials, and a Co-Director of the MPCCC.
After training in medical oncology at the Ludwig Institute in Melbourne, Prof Shackleton undertook PhD studies at the Walter and Eliza Hall Institute of Medical Research (WEHI) and post-doctoral work at the University of Michigan, USA, with resultant publications in Nature, Cell, Cancer Cell and the New England Journal of Medicine.
He was awarded the 2006 Victorian Premier’s Award for Medical Research, a 2010 NHMRC Achievement Award, a 2011 Pfizer Australia Fellowship, and the Australian Science Minister’s Prize for Life Scientist of the Year in 2012.
Professor Shackleton’s main clinical interests are centred on patients diagnosed with skin cancer, including melanoma. His research interests include cancer biology, developmental biology, oncogenic signalling pathways and clinical trials.
